Artivion Inc (AORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Artivion Inc (Artivion), formerly CryoLife Inc, is a medical device company that manufactures and distributes biosurgical devices and implantable human tissues for cardiac and vascular surgical procedures for the treatment of aortic disease. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, bovine pericardium, and mitral chordal repair products, photofix products and Jotec products. The company products includes physicians, cardiac surgeons, hospitals, and medical institutions. The company has manufacturing facilities in Texas and Georgia in the US and Hechinger, Germany. The company distributes its products through a network of the direct sales force in the UK, Austria, France, Germany, Ireland, and Switzerland, and independent distributors in the rest of Europe, the Middle East, and Africa. It commercializes products in more than 85 countries worldwide. Artivion is headquartered in Atlanta, Georgia, the US.Artivion Inc Key Recent Developments
- May 04, 2023: Artivion Reports First Quarter 2023 Financial Results
- Feb 16, 2023: Artivion Reports Fourth Quarter and Full Year 2022 Financial Results
- Feb 02, 2023: Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2022 Financial Results
- Sep 29, 2022: Elizabeth Hoff Joins Artivion Board of Directors
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Medical Solutions Group Plc
- W. L. Gore & Associates Inc
- MAQUET, Inc.
- Abbott Laboratories
- Pfizer Inc
- Medtronic Plc
- CR Bard Inc
- Ethicon US LLC
- Edwards Lifesciences Corp